| 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus M Aringer, C K Arthritis and Rheumatism 71 (9), 2019 | 2697 | 2019 |
| American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis BH Hahn, MA Mcmahon, A Wilkinson, WD Wallace, DI Daikh, ... Arthritis care & research 64 (6), 797-808, 2012 | 1722 | 2012 |
| Idiopathic nonspecific interstitial pneumonia: lung manifestation of undifferentiated connective tissue disease? BW Kinder, HR Collard, L Koth, DI Daikh, PJ Wolters, B Elicker, KD Jones, ... American journal of respiratory and critical care medicine 176 (7), 691-697, 2007 | 456 | 2007 |
| Randomised double blind trial of etoricoxib and indometacin in treatment of acute gouty arthritis HR Schumacher Jr, JA Boice, DI Daikh, S Mukhopadhyay, K Malmstrom, ... Bmj 324 (7352), 1488-1492, 2002 | 356 | 2002 |
| An inactivating point mutation in the inhibitory wedge of CD45 causes lymphoproliferation and autoimmunity R Majeti, Z Xu, TG Parslow, JL Olson, DI Daikh, N Killeen, A Weiss Cell 103 (7), 1059-1070, 2000 | 313 | 2000 |
| Suppression of disease in New Zealand Black/New Zealand White lupus-prone mice by adoptive transfer of ex vivo expanded regulatory T cells KJ Scalapino, Q Tang, JA Bluestone, ML Bonyhadi, DI Daikh The Journal of Immunology 177 (3), 1451-1459, 2006 | 310 | 2006 |
| Long-term inhibition of murine lupus by brief simultaneous blockade of the B7/CD28 and CD40/gp39 costimulation pathways. DI Daikh, BK Finck, PS Linsley, D Hollenbaugh, D Wofsy Journal of immunology (Baltimore, Md.: 1950) 159 (7), 3104-3108, 1997 | 274 | 1997 |
| Cutting edge: reversal of murine lupus nephritis with CTLA4Ig and cyclophosphamide DI Daikh, D Wofsy The Journal of Immunology 166 (5), 2913-2916, 2001 | 251 | 2001 |
| Treatment of lupus nephritis with abatacept: the abatacept and cyclophosphamide combination efficacy and safety study ACCESS Trial Group Arthritis & Rheumatology 66 (11), 3096-3104, 2014 | 236 | 2014 |
| CTLA‐4: a key regulatory point in the control of autoimmune disease KJ Scalapino, DI Daikh Immunological reviews 223 (1), 143-155, 2008 | 227 | 2008 |
| An orally bioavailable spleen tyrosine kinase inhibitor delays disease progression and prolongs survival in murine lupus FR Bahjat, PR Pine, A Reitsma, G Cassafer, M Baluom, S Grillo, B Chang, ... Arthritis & Rheumatism 58 (5), 1433-1444, 2008 | 200 | 2008 |
| A randomized trial of stress management for the prevention of new brain lesions in MS DC Mohr, J Lovera, T Brown, B Cohen, T Neylan, R Henry, J Siddique, ... Neurology 79 (5), 412-419, 2012 | 184 | 2012 |
| Performance of antinuclear antibodies for classifying systemic lupus erythematosus: a systematic literature review and meta‐regression of diagnostic data N Leuchten, A Hoyer, R Brinks, M Schoels, M Schneider, J Smolen, ... Arthritis care & research 70 (3), 428-438, 2018 | 168 | 2018 |
| Accelerated nodulosis and vasculitis following etanercept therapy for rheumatoid arthritis G Cunnane, M Warnock, KH Fye, DI Daikh Arthritis Care & Research 47 (4), 445-449, 2002 | 134 | 2002 |
| Developing and refining new candidate criteria for systemic lupus erythematosus classification: an international collaboration SK Tedeschi, SR Johnson, D Boumpas, D Daikh, T Dörner, D Jayne, ... Arthritis care & research 70 (4), 571-581, 2018 | 125 | 2018 |
| Choosing wisely: the American College of Rheumatology's Top 5 list of things physicians and patients should question J Yazdany, G Schmajuk, M Robbins, D Daikh, A Beall, E Yelin, J Barton, ... Arthritis care & research 65 (3), 329-339, 2013 | 112 | 2013 |
| Catastrophic antiphospholipid syndrome. Response to repeated plasmapheresis over three years CM Neuwelt, DI Daikh, JA Linfoot, DA Pfister, RG Young, RL Webb, ... Arthritis & Rheumatism: Official Journal of the American College of …, 1997 | 102 | 1997 |
| Common language description of the term rheumatic and musculoskeletal diseases (RMD s) for use in communication with the lay public, healthcare providers, and other … D Van Der Heijde, DI Daikh, N Betteridge, GR Burmester, AL Hassett, ... Arthritis & rheumatology 70 (6), 826-831, 2018 | 93 | 2018 |
| Identification of risk factors for elevated transaminases in methotrexate users through an electronic health record G Schmajuk, Y Miao, J Yazdany, WJ Boscardin, DI Daikh, MA Steinman Arthritis care & research 66 (8), 1159-1166, 2014 | 87 | 2014 |
| Block and tackle: CTLA4Ig takes on lupus A Davidson, B Diamond, D Wofsy, D Daikh Lupus 14 (3), 197-203, 2005 | 81 | 2005 |
